PTC Therapeutics, Inc. (PTCT)
NASDAQ·Healthcare·Biotechnology
$64.71
-1.12%
Mkt Cap $5.47B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (36 analysts)
$106.00
Range $85.00 – $137.00
Implied Upside
+63.8%
Consensus $106.00 vs current $64.71
NASDAQ·Healthcare·Biotechnology
$64.71
-1.12%
Mkt Cap $5.47B
Buy
11
Hold
0
Sell
0
Price Target (36 analysts)
$106.00
Range $85.00 – $137.00
+63.8%
Consensus $106.00 vs current $64.71